![]()
|
|
||||||||
J. Biol. Chem., Vol. 263, Issue 5, 2223-2229, Feb, 1988
AJ Marcus, LB Safier, HL Ullman, N Islam, MJ Broekman, JR Falck, S Fischer and C von Schacky
In the course of a cell-cell interaction, 12-HETE (12-hydroxy-5,8,10,14-
eicosatetraenoic acid), the arachidonic acid lipoxygenase product released
from stimulated platelets, is metabolized by a cytochrome P- 450 enzyme
system in unstimulated neutrophils to 12,20-DiHETE (12,20-
dihydroxy-5,8,10,14-eicosatetraenoic acid). This report describes time-
dependent formation of a new eicosanoid by unstimulated neutrophils exposed
to 12-HETE, which is more polar than 12,20-DiHETE (reversed- phase high
performance liquid chromatography). Time course studies indicated that the
precursor compound of this new eicosanoid was 12,20- DiHETE. This was
determined by incubation of purified 12,20-DiHETE with neutrophils, which
resulted in a progressive decrease in 12,20-DiHETE as formation of the
polar metabolite increased. In the absence of neutrophils, 12,20-DiHETE was
quantitatively unchanged. The new metabolite of 12,20-DiHETE was identified
as 12-hydroxyeicosatetraen- 1,20-dioic acid, based upon its UV spectrum,
co-chromatography with a chemically synthesized standard in both high
performance liquid chromatography and thin layer chromatography systems,
and gas chromatography-mass spectrometry. Formation of 12-HETE-1,20-dioic
acid was partially inhibited by 20-hydroxy-LTB4. This indicated that the
neutrophil dehydrogenase responsible for further metabolism of 12,20-
DiHETE may also be involved in conversion of 20-hydroxy-LTB4 to 20-
carboxy-LTB4. The 12,20-DiHETE dehydrogenase enzyme system specifically
requires NAD as cofactor and has subcellular components in both cytosolic
and microsomal fractions which are synergistic in their activity. These
results provide additional evidence for the occurrence of multicellular
metabolic events during hemostasis, thrombosis, and the inflammatory
response.
Platelet-neutrophil interactions. (12S)-hydroxyeicosatetraen-1,20-dioic acid: a new eicosanoid synthesized by unstimulated neutrophils from (12S)-20-dihydroxyeicosatetraenoic acid
Department of Medicine, New York Veterans Administration Medical Center, New York 10010.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. J. Marcus, M. J. Broekman, J. H. F. Drosopoulos, N. Islam, D. J. Pinsky, C. Sesti, and R. Levi Metabolic Control of Excessive Extracellular Nucleotide Accumulation by CD39/Ecto-Nucleotidase-1: Implications for Ischemic Vascular Diseases J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 9 - 16. [Abstract] [Full Text] |
||||
![]() |
R. Altman, A. Scazziota, J. Rouvier, M. T. Santos, J. Valles, J. Aznar, A. J. Marcus, and M. J. Broekman Daily 50 mg or 500 mg Aspirin Does Not Affect the Cooperation of Arachidonic Acid and ADP on Platelet Aggregation • Response Circulation, January 13, 1998; 97(1): 118 - 119. [Full Text] |
||||
![]() |
A. Kumar, J. L. Hoover, C. A. Simmons, V. Lindner, and R. J. Shebuski Remodeling and Neointimal Formation in the Carotid Artery of Normal and P-Selectin–Deficient Mice Circulation, December 16, 1997; 96(12): 4333 - 4342. [Abstract] [Full Text] |
||||
![]() |
A. J. Marcus Aspirin as Prophylaxis against Colorectal Cancer N. Engl. J. Med., September 7, 1995; 333(10): 656 - 658. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |